Actinium Pharmaceuticals Announces Actimab-A Intellectual Property And Manufacturing Advances And Provides NYSE American Listing Update
ATNM•Reuters source details
Source text: ID:nPn95MsFRa
Further company coverage: ATNM.A
Company announces Actimab-A intellectual property and manufacturing advances
- Actinium Pharmaceuticals announces Actimab-A intellectual property and manufacturing advances and provides NYSE American listing update
- Actinium Pharmaceuticals amends IND to add manufacturer for CRADA and company studies; milestones expected H2 2026-2027
Related News
Cosan 2Q26 net loss narrows 66% to R$ 320 million; revenue rises 3% to R$ 10.78 billion
CSAN•
Wheels Up Chief Sales Officer Mark Briffa to depart, Chief Digital Officer David Godsman named interim sales lead
UP•
